About
Oncolytic Virus
Areas of Focus
Categories
Virus TechnologySan Diego & Southern California
Team (12)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
52
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Today
Hover over trial bars to see details
Recent Trials
NCT01443260Lead Sponsor
A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
PHASE1/PHASE2Completed
9 participants
Started: Feb 29, 2012 · Completed: Sep 30, 2014
NCT00794131Lead Sponsor
Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors
PHASE1Completed
43 participants
Started: Nov 30, 2008 · Completed: Nov 30, 2015
Locations (1)
Headquarters
Westlake Village, CA, United States
Map
Loading map...